Thrombopoietin levels increased in patients with severe acute respiratory syndrome.
Identifieur interne : 001979 ( PubMed/Checkpoint ); précédent : 001978; suivant : 001980Thrombopoietin levels increased in patients with severe acute respiratory syndrome.
Auteurs : Mo Yang [République populaire de Chine] ; Margaret H L. Ng ; Chi Kong Li ; Paul K S. Chan ; Chang Liu ; Jie Yu Ye ; Beng H. ChongSource :
- Thrombosis research [ 0049-3848 ] ; 2008.
Descripteurs français
- KwdFr :
- Analyse de régression, Antigènes CD34 (biosynthèse), Cellules souches, Cellules souches hématopoïétiques (cytologie), Facteur de croissance transformant bêta (immunologie), Humains, Microscopie de fluorescence, Modèles biologiques, Mégacaryocytes (cytologie), Régulation de l'expression des gènes, Syndrome respiratoire aigu sévère (sang), Syndrome respiratoire aigu sévère (virologie), Test ELISA (), Thrombopoïétine (biosynthèse), Thrombopénie (génétique), Thrombopénie (sang), Virus du SRAS (métabolisme).
- MESH :
- biosynthèse : Antigènes CD34, Thrombopoïétine.
- cytologie : Cellules souches hématopoïétiques, Mégacaryocytes.
- génétique : Thrombopénie.
- immunologie : Facteur de croissance transformant bêta.
- métabolisme : Virus du SRAS.
- sang : Syndrome respiratoire aigu sévère, Thrombopénie.
- virologie : Syndrome respiratoire aigu sévère.
- Analyse de régression, Cellules souches, Humains, Microscopie de fluorescence, Modèles biologiques, Régulation de l'expression des gènes, Test ELISA.
English descriptors
- KwdEn :
- Antigens, CD34 (biosynthesis), Enzyme-Linked Immunosorbent Assay (methods), Gene Expression Regulation, Hematopoietic Stem Cells (cytology), Humans, Megakaryocytes (cytology), Microscopy, Fluorescence, Models, Biological, Regression Analysis, SARS Virus (metabolism), Severe Acute Respiratory Syndrome (blood), Severe Acute Respiratory Syndrome (virology), Stem Cells, Thrombocytopenia (blood), Thrombocytopenia (genetics), Thrombopoietin (biosynthesis), Transforming Growth Factor beta (immunology).
- MESH :
- chemical , biosynthesis : Antigens, CD34, Thrombopoietin.
- blood : Severe Acute Respiratory Syndrome, Thrombocytopenia.
- cytology : Hematopoietic Stem Cells, Megakaryocytes.
- genetics : Thrombocytopenia.
- chemical , immunology : Transforming Growth Factor beta.
- metabolism : SARS Virus.
- methods : Enzyme-Linked Immunosorbent Assay.
- virology : Severe Acute Respiratory Syndrome.
- Gene Expression Regulation, Humans, Microscopy, Fluorescence, Models, Biological, Regression Analysis, Stem Cells.
Abstract
Hematological changes in patients with Severe Acute Respiratory Syndrome (SARS) are common and frequently include thrombocytopenia. Using a ELISA method, we found an increase in thrombopoietin (TPO) levels in the plasma of convalesced SARS patients (290+/-53 pg/ml) and active SARS patients (251+/-23 pg/ml) comparing to that from normal control patients (228+/-17 pg/ml). In addition, the plasma from active SARS patients had an inhibitory effect on CFU-MK formation, which could be neutralized by anti-TGF-beta antibodies. In the experiment to determine whether SARS-CoV can directly infect hematopoietic stem cells and megakaryocytic cells, incubation of the cells with SARS-CoV did not show active infection. Our findings of increased TPO levels in the plasma of SARS patients provide a possible explanation for the genesis of thrombocytosis, which frequently develops from thrombocytopenia in SARS patients.
DOI: 10.1016/j.thromres.2007.12.021
PubMed: 18314161
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:18314161Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Thrombopoietin levels increased in patients with severe acute respiratory syndrome.</title>
<author><name sortKey="Yang, Mo" sort="Yang, Mo" uniqKey="Yang M" first="Mo" last="Yang">Mo Yang</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, PR China. yangmo@hkucc.hku.hk</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong</wicri:regionArea>
<wicri:noRegion>Hong Kong</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ng, Margaret H L" sort="Ng, Margaret H L" uniqKey="Ng M" first="Margaret H L" last="Ng">Margaret H L. Ng</name>
</author>
<author><name sortKey="Li, Chi Kong" sort="Li, Chi Kong" uniqKey="Li C" first="Chi Kong" last="Li">Chi Kong Li</name>
</author>
<author><name sortKey="Chan, Paul K S" sort="Chan, Paul K S" uniqKey="Chan P" first="Paul K S" last="Chan">Paul K S. Chan</name>
</author>
<author><name sortKey="Liu, Chang" sort="Liu, Chang" uniqKey="Liu C" first="Chang" last="Liu">Chang Liu</name>
</author>
<author><name sortKey="Ye, Jie Yu" sort="Ye, Jie Yu" uniqKey="Ye J" first="Jie Yu" last="Ye">Jie Yu Ye</name>
</author>
<author><name sortKey="Chong, Beng H" sort="Chong, Beng H" uniqKey="Chong B" first="Beng H" last="Chong">Beng H. Chong</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18314161</idno>
<idno type="pmid">18314161</idno>
<idno type="doi">10.1016/j.thromres.2007.12.021</idno>
<idno type="wicri:Area/PubMed/Corpus">001B99</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B99</idno>
<idno type="wicri:Area/PubMed/Curation">001B99</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B99</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001979</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001979</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Thrombopoietin levels increased in patients with severe acute respiratory syndrome.</title>
<author><name sortKey="Yang, Mo" sort="Yang, Mo" uniqKey="Yang M" first="Mo" last="Yang">Mo Yang</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, PR China. yangmo@hkucc.hku.hk</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong</wicri:regionArea>
<wicri:noRegion>Hong Kong</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ng, Margaret H L" sort="Ng, Margaret H L" uniqKey="Ng M" first="Margaret H L" last="Ng">Margaret H L. Ng</name>
</author>
<author><name sortKey="Li, Chi Kong" sort="Li, Chi Kong" uniqKey="Li C" first="Chi Kong" last="Li">Chi Kong Li</name>
</author>
<author><name sortKey="Chan, Paul K S" sort="Chan, Paul K S" uniqKey="Chan P" first="Paul K S" last="Chan">Paul K S. Chan</name>
</author>
<author><name sortKey="Liu, Chang" sort="Liu, Chang" uniqKey="Liu C" first="Chang" last="Liu">Chang Liu</name>
</author>
<author><name sortKey="Ye, Jie Yu" sort="Ye, Jie Yu" uniqKey="Ye J" first="Jie Yu" last="Ye">Jie Yu Ye</name>
</author>
<author><name sortKey="Chong, Beng H" sort="Chong, Beng H" uniqKey="Chong B" first="Beng H" last="Chong">Beng H. Chong</name>
</author>
</analytic>
<series><title level="j">Thrombosis research</title>
<idno type="ISSN">0049-3848</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antigens, CD34 (biosynthesis)</term>
<term>Enzyme-Linked Immunosorbent Assay (methods)</term>
<term>Gene Expression Regulation</term>
<term>Hematopoietic Stem Cells (cytology)</term>
<term>Humans</term>
<term>Megakaryocytes (cytology)</term>
<term>Microscopy, Fluorescence</term>
<term>Models, Biological</term>
<term>Regression Analysis</term>
<term>SARS Virus (metabolism)</term>
<term>Severe Acute Respiratory Syndrome (blood)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Stem Cells</term>
<term>Thrombocytopenia (blood)</term>
<term>Thrombocytopenia (genetics)</term>
<term>Thrombopoietin (biosynthesis)</term>
<term>Transforming Growth Factor beta (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Analyse de régression</term>
<term>Antigènes CD34 (biosynthèse)</term>
<term>Cellules souches</term>
<term>Cellules souches hématopoïétiques (cytologie)</term>
<term>Facteur de croissance transformant bêta (immunologie)</term>
<term>Humains</term>
<term>Microscopie de fluorescence</term>
<term>Modèles biologiques</term>
<term>Mégacaryocytes (cytologie)</term>
<term>Régulation de l'expression des gènes</term>
<term>Syndrome respiratoire aigu sévère (sang)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Test ELISA ()</term>
<term>Thrombopoïétine (biosynthèse)</term>
<term>Thrombopénie (génétique)</term>
<term>Thrombopénie (sang)</term>
<term>Virus du SRAS (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Antigens, CD34</term>
<term>Thrombopoietin</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Antigènes CD34</term>
<term>Thrombopoïétine</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
<term>Thrombocytopenia</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr"><term>Cellules souches hématopoïétiques</term>
<term>Mégacaryocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Hematopoietic Stem Cells</term>
<term>Megakaryocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Thrombocytopenia</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Thrombopénie</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Facteur de croissance transformant bêta</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Transforming Growth Factor beta</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Enzyme-Linked Immunosorbent Assay</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
<term>Thrombopénie</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Gene Expression Regulation</term>
<term>Humans</term>
<term>Microscopy, Fluorescence</term>
<term>Models, Biological</term>
<term>Regression Analysis</term>
<term>Stem Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Analyse de régression</term>
<term>Cellules souches</term>
<term>Humains</term>
<term>Microscopie de fluorescence</term>
<term>Modèles biologiques</term>
<term>Régulation de l'expression des gènes</term>
<term>Test ELISA</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Hematological changes in patients with Severe Acute Respiratory Syndrome (SARS) are common and frequently include thrombocytopenia. Using a ELISA method, we found an increase in thrombopoietin (TPO) levels in the plasma of convalesced SARS patients (290+/-53 pg/ml) and active SARS patients (251+/-23 pg/ml) comparing to that from normal control patients (228+/-17 pg/ml). In addition, the plasma from active SARS patients had an inhibitory effect on CFU-MK formation, which could be neutralized by anti-TGF-beta antibodies. In the experiment to determine whether SARS-CoV can directly infect hematopoietic stem cells and megakaryocytic cells, incubation of the cells with SARS-CoV did not show active infection. Our findings of increased TPO levels in the plasma of SARS patients provide a possible explanation for the genesis of thrombocytosis, which frequently develops from thrombocytopenia in SARS patients.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18314161</PMID>
<DateCompleted><Year>2008</Year>
<Month>11</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>03</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0049-3848</ISSN>
<JournalIssue CitedMedium="Print"><Volume>122</Volume>
<Issue>4</Issue>
<PubDate><Year>2008</Year>
</PubDate>
</JournalIssue>
<Title>Thrombosis research</Title>
<ISOAbbreviation>Thromb. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Thrombopoietin levels increased in patients with severe acute respiratory syndrome.</ArticleTitle>
<Pagination><MedlinePgn>473-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2007.12.021</ELocationID>
<Abstract><AbstractText>Hematological changes in patients with Severe Acute Respiratory Syndrome (SARS) are common and frequently include thrombocytopenia. Using a ELISA method, we found an increase in thrombopoietin (TPO) levels in the plasma of convalesced SARS patients (290+/-53 pg/ml) and active SARS patients (251+/-23 pg/ml) comparing to that from normal control patients (228+/-17 pg/ml). In addition, the plasma from active SARS patients had an inhibitory effect on CFU-MK formation, which could be neutralized by anti-TGF-beta antibodies. In the experiment to determine whether SARS-CoV can directly infect hematopoietic stem cells and megakaryocytic cells, incubation of the cells with SARS-CoV did not show active infection. Our findings of increased TPO levels in the plasma of SARS patients provide a possible explanation for the genesis of thrombocytosis, which frequently develops from thrombocytopenia in SARS patients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>Mo</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, PR China. yangmo@hkucc.hku.hk</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ng</LastName>
<ForeName>Margaret H L</ForeName>
<Initials>MH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Chi Kong</ForeName>
<Initials>CK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chan</LastName>
<ForeName>Paul K S</ForeName>
<Initials>PK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Chang</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ye</LastName>
<ForeName>Jie Yu</ForeName>
<Initials>JY</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chong</LastName>
<ForeName>Beng H</ForeName>
<Initials>BH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2008</Year>
<Month>03</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Thromb Res</MedlineTA>
<NlmUniqueID>0326377</NlmUniqueID>
<ISSNLinking>0049-3848</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018952">Antigens, CD34</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9014-42-0</RegistryNumber>
<NameOfSubstance UI="D013926">Thrombopoietin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D018952" MajorTopicYN="N">Antigens, CD34</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006412" MajorTopicYN="N">Hematopoietic Stem Cells</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008533" MajorTopicYN="N">Megakaryocytes</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013921" MajorTopicYN="N">Thrombocytopenia</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013926" MajorTopicYN="N">Thrombopoietin</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year>
<Month>05</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2007</Year>
<Month>11</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2007</Year>
<Month>12</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2008</Year>
<Month>3</Month>
<Day>4</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>12</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2008</Year>
<Month>3</Month>
<Day>4</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">18314161</ArticleId>
<ArticleId IdType="pii">S0049-3848(07)00489-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.thromres.2007.12.021</ArticleId>
<ArticleId IdType="pmc">PMC7112012</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>BMJ. 2003 Jun 21;326(7403):1358-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12816821</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2005 Feb;75(2):185-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15602737</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15616839</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Int J Mol Med. 2004 Aug;14(2):311-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15254784</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12682352</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Pediatr Res. 2003 Sep;54(3):344-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12815110</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Hematology. 2005 Apr;10(2):101-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16019455</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2004 Aug 1;190(3):515-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15243926</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2004 Apr 15;172(8):4676-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15067041</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Microbes Infect. 2005 Mar;7(3):427-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15784184</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Invest. 2005 Dec;115(12):3339-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16322778</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Br J Haematol. 2000 Oct;111(1):371-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11091227</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Platelets. 2006 Aug;17(5):347-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16928610</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Br J Haematol. 2004 Jan;124(2):211-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14687032</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Mar;10(3):530-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15109430</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><noCountry><name sortKey="Chan, Paul K S" sort="Chan, Paul K S" uniqKey="Chan P" first="Paul K S" last="Chan">Paul K S. Chan</name>
<name sortKey="Chong, Beng H" sort="Chong, Beng H" uniqKey="Chong B" first="Beng H" last="Chong">Beng H. Chong</name>
<name sortKey="Li, Chi Kong" sort="Li, Chi Kong" uniqKey="Li C" first="Chi Kong" last="Li">Chi Kong Li</name>
<name sortKey="Liu, Chang" sort="Liu, Chang" uniqKey="Liu C" first="Chang" last="Liu">Chang Liu</name>
<name sortKey="Ng, Margaret H L" sort="Ng, Margaret H L" uniqKey="Ng M" first="Margaret H L" last="Ng">Margaret H L. Ng</name>
<name sortKey="Ye, Jie Yu" sort="Ye, Jie Yu" uniqKey="Ye J" first="Jie Yu" last="Ye">Jie Yu Ye</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Yang, Mo" sort="Yang, Mo" uniqKey="Yang M" first="Mo" last="Yang">Mo Yang</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001979 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001979 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:18314161 |texte= Thrombopoietin levels increased in patients with severe acute respiratory syndrome. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:18314161" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |